NCT07505225

Brief Summary

The study aimed to determine the effects of virtual reality headsets and on-screen video viewing methods on physiological parameters (heart rate, oxygen saturation, and respiration), procedural pain, fear, and emotional reactions during peripheral venous catheter placement in children aged 7-12. A parallel-group, repeated-measurement (pretest, interim, and post-test) randomized controlled trial was conducted between January 18 and June 19, 2025, with children aged 7-12 (Virtual Reality Headset Group-VRHG=22, On-screen Video Viewing Group-OVVG=22, Control Group-CG=22) who were followed in the paediatric emergency department of a university hospital in Konya. The data collection tools in the study were: Information Form, Physiological Parameters Assessment Form, Wong-Baker FACES Pain Rating Scale (WB-FPRS), Children's Fear Scale (CFS), and Children's Emotional Manifestation Scale (CEMS) were used. Two minutes before the peripheral venous catheter placement procedure, the "Under the Sea" video was shown to VRHG and OVVG, and it continued for two minutes after the procedure. Routine hospital practice was continued for the CG. Data were entered into SPSS-25.0, and descriptive statistics, chi-square test, Kruskal-Wallis, one-way ANOVA, one-way ANOVA for repeated measures, and two-way ANOVA were used for data analysis. Statistical significance was set at 0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 23, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
Last Updated

April 2, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

August 23, 2025

Last Update Submit

April 1, 2026

Conditions

Keywords

patientchild

Outcome Measures

Primary Outcomes (4)

  • Physiological Parameters Assessment Form

    This form was designed to measure physiological parameters affected by pain (pulse rate, respiratory rate, and oxygen saturation). Blood pressure and fever parameters, which are not affected by short-term procedural pain as mentioned in the literature, were not included in this form. The aim of the study is to ensure that the child's physiological parameters remain within normal limits in the intervention groups.

    Pre-test (2 minutes before the procedure) Intermediate measurement (during the procedure) Post-test (2 minutes after the procedure)

  • Wong-Baker Faces Pain Raiting Scale (WB-FPRS)

    Developed by Wong and Connie Morain Baker in 1981 and updated in 1983, the scale is used to measure pain in children aged 3-18 years. The scale includes five different facial expressions, each corresponding to a number between 0 and 10. Higher numbers indicate higher pain levels. In this study, it was expected that the intervention groups would have lower pain scores.

    Pre-test (2 minutes before the procedure) Intermediate measurement (during the procedure) Post-test (2 minutes after the procedure)

  • Children's Fear Scale (CFS)

    CFS, developed by McMurtry et al. (2011), is a visual scale containing five different facial expressions (hairless, gender-informed) and a rapid scale ranging from 0 (neutral facial expression) to 4 (extremely fearful-anxious facial expression) for each facial expression. A higher score on the scale indicates a greater capacity for fear in adolescents. The study expects the intervention groups to have lower CFS scores.

    Pre-test (2 minutes before the procedure) Intermediate measurement (during the procedure) Post-test (2 minutes after the procedure)

  • Children's Emotional Manifestation Scale (CEMS)

    Li and Lopez (2005) developed a comprehensive five-section assessment scale, comprising facial expression, voice acting, activity, interaction, and cooperation, scored from 1 to 5. In this context, scores on the Critical Disorder of Emotional State (CDVD) range from 5 (lowest) to 25 (highest), with lower scores indicating a heightened negative emotional state. Results indicated that intervention groups showed significantly lower mean scale scores.

    Pre-test (2 minutes before the procedure) Intermediate measurement (during the procedure) Post-test (2 minutes after the procedure)

Study Arms (3)

Virtual Reality Headset Group (VRHG)

EXPERIMENTAL

The use of virtual reality (VR) headsets to present audiovisual content to children.

Other: Virtual Reality Headset Group (VRHG)

On-screen Video Viewing Group (OVVG)

EXPERIMENTAL

The use of on-screen audiovisual content for children

Other: On-screen Video Viewing Group (OVVG)

Control Group (CG)

OTHER

No interventions beyond standard service routines for peripheral venous access were performed.

Other: Control Group (CG)

Interventions

The child and their family in this group were given information about virtual reality goggles, infection control materials (a disposable surgical cap and a virtual reality goggle pad), a saturation device, and an underwater video (https://www.youtube.com/watch?v=XEkUy7a8vfI). The headset was disinfected before the procedure. The virtual reality goggles were adjusted to fit the child's head, and the lens was adjusted according to the child's feedback to ensure video clarity. The video began 2 minutes before the peripheral venous catheter placement procedure. The peripheral venous catheter placement was performed by the ward head nurse. After the peripheral venous catheter was placed, the child watched the video for another two minutes. The child's total video viewing time was 4 minutes. The headset was disinfected after the procedure.

Virtual Reality Headset Group (VRHG)

The materials to be used for the child and their family in this group, including a phone screen, screen holder, headphones, infection control materials (ear cap), a saturation device, and a submarine video (https://www.youtube.com/watch?v=XEkUy7a8vfI), were introduced.Before the procedure, the phone screen, screen holder, and headphones were disinfected. After the phone screen was placed in the holder, it was placed on a table 50 cm away from the child's eye level in the area where the procedure would be performed. The child's ability to see the screen properly was assessed. Based on the child's feedback, the table was set to 45-55 cm. The headphones to be used in the procedure were placed appropriately on the child's head and ears. The headphones' volume was adjusted to the appropriate level for the child based on the child's feedback. The video began 2 minutes before the peripheral venous catheter placement procedure. The peripheral venous catheter placement procedure was performed

On-screen Video Viewing Group (OVVG)

In the pediatric emergency department, no interventions beyond standard service routines for peripheral venous access were performed; however, for this study, CG components and a saturation device were introduced. Peripheral venous placement was performed by the registered service supervisor.

Control Group (CG)

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The child should be monitored at the hospital for a minimum of 30 minutes and a maximum of 6 hours during the planned training.
  • The child should be able to understand and speak Turkish fluently.
  • Child must be aged 7-12 years old.
  • Prior to the assessment process, the child's Wong-Baker Facial Expression Assessment Scale score must be 0.
  • There should be no condition in the hand and arm area that would prevent the establishment of planned peripheral venous access.

You may not qualify if:

  • The child or parent does not wish to participate in the study
  • The child has a history of sedative or narcotic substance use within the last 24 hours
  • The child has received analgesia within the last 6 hours
  • The child has a visual health problem
  • The child has a hearing health problem
  • The child has a neurological disease that may be triggered by sight and sound
  • The child has a history of syncope during invasive procedures (blood sampling, intravenous access, etc)
  • The child has loss of sensation or tissue in the extremities (e.g., plaster casts) that would prevent intravenous access
  • The child has a wound/trauma to the scalp or any part of the head
  • The child has a health problem requiring isolation
  • The child or parent expressing a desire to withdraw from the study at any stage of the research.
  • The child experiencing health problems during the procedure (syncope, seizures, etc.).
  • Initiating any medication or fluid treatment within 2 minutes of intravenous access (until the final test measurement).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selçuk University

Konya, Konya, 42208, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Sevil Özkan, Assist Prof

    Selcuk University Faculty of Nursing

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Only the statistician was masked.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Pediatric nurse, master degree

Study Record Dates

First Submitted

August 23, 2025

First Posted

April 1, 2026

Study Start

January 18, 2025

Primary Completion

June 19, 2025

Study Completion

July 18, 2025

Last Updated

April 2, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

If necessary, researchers will be contacted, and the sharing status will be reviewed again based on the study's type and purpose.

Locations